✦ LIBER ✦
Use of a Constitutively Active Hypoxia-Inducible Factor-1 Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients. Phase I Dose-Escalation Experience
✍ Scribed by Rajagopalan, S.; Olin, J.; Deitcher, S.; Pieczek, A.; Laird, J.; Grossman, P. M.; Goldman, C. K.; McEllin, K.; Kelly, R.; Chronos, N.
- Book ID
- 111912671
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2007
- Tongue
- English
- Weight
- 821 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0009-7322
No coin nor oath required. For personal study only.